Probing ligand binding interactions of human alpha glucosidase by homology modeling and molecular docking

International Journal of Integrative Biology

Volumn 2, Issue 2, 2008, Pages 116-121

  Saqib, Uzma ^a   Siddiqi, Mohammad Imran ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Homology modeling; Human neutral alpha glucosidase C (GANC_HUMAN); Molecular docking; Type2 diabetes; Virtual screening

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME STRUCTURE; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PROTEIN INTERACTION; STRUCTURAL HOMOLOGY; SULFOLOBUS SOLFATARICUS; THREE DIMENSIONAL IMAGING;

EID: 70249122682     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Altschul SF, Gish W et al. (1990) Basic local alignment search tool. J Mol Biol, 215(3): 403-410.
2. Böhm HJ (1998) Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J. Comput. Aided Mol. Design 12(4):309-23.
3. Braun C, Brayer GD et al. (1995) Mechanism-based inhibition of yeast alpha-glucosidase and human pancreatic alpha-amylase by a new class of inhibitors .2-Deoxy-2, 2-difluoro-alpha-glycosides. J. Biol. Chem. 270(45): 26778-26781.
4. Clissold SP, Edwards C (1988) Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 35: 214-43.
5. Dwek RA, Butters TD et al. (2002) Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Disc.1(1): 65-75.
6. Ernst HA, Lo Leggio L et al. (2006) Structure of the Sulfolobus solfataricus alpha-glucosidase: implications for domain conservation and substrate recognition in GH31. J. Mol.Biol. 358: 1106-24.
7. Matsuura H et al. (2004) FlexX, version 1.13.5; Sankt Augustin, Germany, BioSolveIT GmbH.Phytochemistry. 65: 91-97.
8. Hillebrand I (1987) Pharmacological modification of digestion and absorption. Diabet Med. 4: 147-50.
9. Hirschhorn R, Huie ML, Kasper JS (2002) Computer assisted cloning of human neutral alpha-glucosidase C (GANC): a new paralog in the glycosyl hydrolase gene family 31. Proc.Natl.Acad.Sci. 99(21): 13642-13646. Insight II Program, Accelrys Inc., San Diego, CA, 2001.
10. Kramer B, Rarey M et al. (1999) Evaluation of the FLEXX Incremental Construction Algorithm for Protein-Ligand Docking. Proteins: Struct., Funct., Genet. 37: 228-241.
11. Kroemer RT, Doughty SW et al. (1996) Prediction of the three-dimensional structure of human interleukin-7 by homology modeling. Protein Eng 9: 493-498.
12. Laskowaski RA, MacArthur MW et al. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
13. Matthias H, Frishman D (2004) STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins.32: 500-502.
14. Mooradian AD, Thurman, JE (1999) Drug therapy of postprandial hyperglycaemia. Drugs. 57(1):19-29.
15. Morris AL, MacArthur MW e.t al. (1992) Stereochemical quality of protein structure coordinates. Proteins, 12, 345-364.
16. Puls W, Krause HP (1979) Delay of carbohydrate absorption by inhibitors of intestinal-glucosidases. Adv Exp Med Biol. 119: 341-6.
17. Ramachandran GN et al. (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol .7: 95-99.
18. Rarey M, Kramer B et al. (1996) A Fast Flexible Docking Method Using an Incremental Construction Algorithm. J. Mol. Biol. 261:470-489.
19. Rarey M, Kramer B et al. (1996) J. Mol. Biol. 261(3):470-89.
20. Robinson KM, Begovic ME, et al. (1991) New potent α-glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes. 40 (7): 825-830.
21. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779-815.
22. Sali A, Overington JP (1994) Derivation of rules for comparative protein modelling from a database of protein structure alignments. Protein Sci. 3: 1582-1596.
23. Sali A, Potterton L et al. (1995) Evaluation of comparative protein modeling by MODELLER. Proteins. 23: 318-326.
24. Sali A (1995) Modeling mutations and homologous proteins. Curr. Opin. Biotechnol. 6: 437-451.
25. Sim L, Quezada Calvillo R, et al. (2008) J.Mol.Biol. 375: 782-92.
26. Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins 17(4):355-62. TRIPOS Inc., 1699 South Hanley Road, St. Louis, MO 63144, USA.
27. Walder K, McMillan J et al. (2002) Calpain 3 gene expression in skeletal muscle is associated with body fat content and measures of insulin resistance.Int J Obes Relat Metab Disord. 26(4): 442-9.
28. Seo WD, Kim JH et al. (2005) Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors. Bioorg. Med. Chem. Lett. 15 (24): 5514-5516.
29. Xu Hai Wei., Dai Gui Fu. et al. (2007) Bioorganic & Medicinal Chemistry, 15: 4247-4255.
30. Yoshikawa M, Murakami T et al.(1998).Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem.Pharm.Bull. 46 (8): 1339-1340.